Loading…
Loading…
MRES does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for MRES and 80,000+ other tickers.
See exactly how MRES's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MRES and 80,000+ other tickers.
Institute of Biomedical Research Corp. (MRES) is a dedicated provider of comprehensive biomedical research and analytical services, operating both within Montenegro and across international markets. The company's core activities encompass fundamental scientific investigation and robust research and development initiatives for new biomedical products, advanced technologies, and innovative diagnostic methods, including experimental medical treatments. MRES also focuses on the creation of novel biomedical and food products. A significant part of its mandate involves regulatory oversight of…
DUBAI, UAE / ACCESS Newswire / January 24, 2025 / Real American Capital Corp (OTC PINK:RLAB), trading as M2MMA, is an avant-garde powerhouse reshaping the combat sports landscape. It is thrilled to announce an appointment to its esteemed Advisory Board.
DUBAI, UAE / ACCESSWIRE / November 25, 2024 / The Institute of Biomedical Research Corp. (OTC PINK:MRES), operating as M2Bio Sciences, is a pioneering biotechnology company dedicated to advancing health and wellness through innovative science-driven solutions. Specialising in researching, developing, and commercialising cutting-edge products in nutrition, health, and sustainability.
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / August 22, 2024 / The Institute of Biomedical Research Corp. (OTC PINK:MRES), a pioneering nutraceutical biotechnology company that delves into the innovative realm of plant-based medicines, healthy food products, and sustainable packaging solutions, is pleased to announce the following updates with its M2Bio Food and Beverage division: M2Bio Food and Beverage, known for its premium, healthy, and sustainably sourced products, is taking a significant step forward by announcing a strategic shift in its product lineup. After several successful years of exploring CBD-infused food products, the company has decided to discontinue this line and refocus efforts on expanding its core offerings.
DUBAI, UNITED ARAB EMIRATES / ACCESSWIRE / May 16, 2024 / Real American Capital Corp (OTC PINK:RLAB), trading as M2MMA, a leader in mixed martial arts, is thrilled to announce the appointment of Sagat Petchyindee (Wirun Phonphimai), the legendary Muay Thai fighter , has joined the M2MMA Advisory Board . Born in 1958, Sagat is renowned for his dominance during the late 20th century, earning him the title of one of the greatest Muay Thai fighters ever.
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / March 22, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specialising in alternative plant-based cannabinoids, medical psilocybin, and cutting-edge mental health therapeutic research driven by artificial intelligence (AI), is pleased to announce the following updates with its M2Bio Food and Beverage division: M2Bio Sciences Food and Beverage had a stellar 2023 The year started with 15 SKUs and ended with 32 SKUs. One of the outstanding new product ranges was the Liviana® Peanut Butter Range, which consists of light roast peanut butter and dark roast peanut butter-both available in smooth and crunchy form.